Unique ID issued by UMIN | UMIN000036323 |
---|---|
Receipt number | R000041364 |
Scientific Title | An enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms. |
Date of disclosure of the study information | 2019/04/01 |
Last modified on | 2020/09/27 11:30:40 |
An enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms.
An enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms.
An enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms.
An enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms.
Japan |
esophageal or gastric neoplasms
Gastroenterology |
Malignancy
NO
Our aim is to verify whether an enhanced recovery protocol of oral intake could improve nutritional status in patients after endoscopic submucosal dissection for esophageal or gastric neoplasms
Efficacy
effect on nutritional status a week after endoscopic submucosal dissection
rate of post-ESD bleeding, rate of ulcer healing 6 weeks after endoscopic submucosal dissection, effect on patients' satisfaction, effect on dietary intake
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Food |
conventional diet form after endoscopic submucosal dissection
enhanced recovery of oral intake after endoscopic submucosal dissection
20 | years-old | <= |
Not applicable |
Male and Female
patients who will undergo endoscopic submucosal dissection for esophageal or gastric neoplasms
(1)a lesion with active gastroduodenal ulcer
(2)a lesion in the remnant stomach
(3)a recurrent lesion after for esophageal or gastric neoplasms
(4)use of dual antiplatelet therapy
(5)severe anemia
(6)severe liver damage or liver cirrhosis
(7)severe renal dysfunction or hemodialysis
(8)oral administration of steroid or immunosuppressive drug
(9)hypersensitivity to vonoprazan
(10)informed consent was not obtained
(11)pregnancy or nursing
(12)inadequacy judged by investigators
50
1st name | Naoto |
Middle name | |
Last name | Iwai |
Fukuchiyama City Hospital
Department of Gastroenterology and Hepatology
620-8505
231 Atsunaka-cho, Fukuchiyama-city, Kyoto
0773-22-2101
na-iwai@koto.kpu-m.ac.jp
1st name | Naoto |
Middle name | |
Last name | Iwai |
Fukuchiyama City Hospital
Department of Gastroenterology and Hepatology
620-8505
231 Atsunaka-cho, Fukuchiyama-city, Kyoto
0773-22-2101
na-iwai@koto.kpu-m.ac.jp
Fukuchiyama City Hospital
Fukuchiyama City Hospital
Local Government
Fukuchiyama City Hospital
231 Atsunaka-cho, Fukuchiyama-city, Kyoto
0773-22-2101
na-iwai@koto.kpu-m.ac.jp
NO
市立福知山市民病院(京都府)
2019 | Year | 04 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2019 | Year | 03 | Month | 28 | Day |
2019 | Year | 03 | Month | 27 | Day |
2019 | Year | 04 | Month | 01 | Day |
2021 | Year | 12 | Month | 31 | Day |
2019 | Year | 03 | Month | 28 | Day |
2020 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041364
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |